Gains and losses of glycoprotein CD44 and secretory component expression in endometrial hyperplasia and neoplasia

European Journal of Gynaecological Oncology

Volumn 23, Issue 5, 2002, Pages 453-456

  Tamiolakis, D ^a   Kotini, A ^a   Cheva, A ^a   Jivannakis, T ^a   Lambropoulou, M ^a   Bobos, M ^a   Vavetsis, S ^a   Papadopoulos, N ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Endometrial hyperplasia; Endometrial neoplasia; Glygoprotein CD44

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOMETRIAL DISEASE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; STROMA CELL;

ADENOCARCINOMA; ANTIGENS, CD44; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SECRETORY COMPONENT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036435335     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Horny H. P., Menke D. M., Kaiserling E.: "Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM". Virchows Arch., 1996, 429, 91.
2. Fox S. B. et al., Cancer Res., 1994, 53, 4539.
3. Haynes B. F., Liao X-P., Patton K. L.: "The transmembrane hyalurinate receptor (CD44): Multiple functions, multiple forms". Cancer Cells, 1991, 3, 347.
4. Ruiz P., Schwarzler C., Gunther T. U.: "CD44 isoforms during differentiation and development". BioEssays, 1994, 17, 17.
5. Springer T. A.: "Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm". Cell, 1994, 76, 301.
6. Thomas L., Byers H. R., Vink J., Stamenkovic I.: "CD44 regulates tumor cell migration on hyaluronate-coated substrates". J. Cell Biol., 1992, 118, 971.
7. Wielega V. J. M., Heider K. H., Offerhaus J. A. et al.: "Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression". Cancer Res., 1993, 53, 4754.
8. Stauder R., Eisterer W., Thaler J., Gunthert U.: "CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor". Blood, 1995, 10, 2885.
9. Terpe H. J., Storkel S., Zimmer U. et al.: "Expression of CD44 isoforms in renal cell tumors: Positive correlation to tumor progression". Am. J. Pathol., 1996, 148, 453.
10. Fujita N., Yaegashi N., Ide et al.: "Expression of CD44 in normal versus tumor endometrial tissues: Possible implications of reduced expression of CD44 in lymph-vascular space involvement of cancer cells". Cancer Res., 1994, 54, 3922.
11. Hong R. L., Pu Y. S., Chu J. S., Lee W. J., Chen Y. C., Wu C. W.: "Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell caminoma" Cancer Lett., 1995, 89, 81.
12. Salmi M., Gron-Virta K., Sointu P., Grenman R., Kalimo H., Jalkanen S.: "Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant tranformation of tumors of squamocellular origin". J. Cell Biol., 1993, 122, 431.
13. Piffko J., Bankfalvi A., Klauke K. et al.: "Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas". J. Oral. Pathol. Med., 1996, 25, 502.
14. Iida N., Bourguignon L. Y.: "Coexpression of CD44 variant (c10/ex14) and CD44s in human mammary epithelial cells promotes tumorigenesis". J. Cell Physiol., 1997, 171, 152.
15. Bankfalvi A., Terpe H-J., Breukelmann D., Bier B., Rempe D., Pschadka G. et al.: "Gains and losses of CD44 expression during breast carcinogenesis and tumor progression". Histopathology, 1998, 33, 107.
16. Nakopoulou L., Minaretzis D., Tsionou C., Mastrominas M.: "Value of immunohistochemical demonstration of several epithelial markers in hyperplastic and neoplastic endometrium". Gynecol. Oncol., 1990, 37 (3), 346.
17. Welch W. R., Scully R. E.: "Precancerous lesions of the endometrium". Hum. Pathol., 1977, 8, 503.
18. Kurman R. J., Kaminski P. F., Norris H. J.: "The behavior of endometrial hyperplasia: A long term study of "untreated" hyperplasia in 170 patients". Cancer, 1985, 56, 403.
19. Frenczy A., Gelfand M.: "The biologic significance of cytologic atypia in progesterone-terated endometrial hyperplasia". Am. J. Obstet. Gynecol., 1989, 160, 126.
20. Scully R. E., Poulson H., Sobin L.: "Histological Typing of the Female Genital Tract Tumors". Berlin, Springer-Verlag, 1984.
21. Tavassoli F, Kraus F. T.: "Endometrial lesions in uteri resected for atypical endometrial hyperplasia". Am. J. Clin. Pathol., 1978, 70, 770.
22. Kurman R. J., Norris H. J.: "Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma". Cancer, 1982, 49, 2547.
23. Chamlian D. L., Taylor H. B.: "Endometrial hyperplasia in young women". Obstet. Gynecol., 1970, 36, 659.
24. Vellios F.: "Endometrial hyperplasias, precursors of endometrial carcinoma". Pathol. Annu., 1972, 7, 201.
25. Hendrickson M. R., Ross J., Kempson R. L.: "Toward the development of morphologic criteria for well-differentiated adenocarcinoma of the endometrium". Am. J. Surg. Pathol., 1983, 7, 819.